NMY-19201-05161 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-01
Dose 1 — Moderna
2021-10-29
Dose 2 — Moderna
2021-11-03
Registered in v-safe
2021-11-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-11-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-07
Health check-in — day 7, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-11-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-28
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-12-05
Survey response — day 35, dose 2
MedDRA: Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: sore throat

MedDRA releases: 2024-11 · check-in free text available
2021-12-10
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2022-01-28
Survey response — 3 months, dose 2
MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: , . . 37,6. . . .

MedDRA releases: 2024-11 · check-in free text available
2022-01-28
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-03
Call 1 — Could Not Reach Participant
2022-02-08
Call 2 — Left Voicemail
2022-05-01
Survey response — 6 months, dose 2
MedDRA: Cough, Rhinitis, Rhinorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: runny nose, rhinitis. and cough

MedDRA releases: 2024-11 · check-in free text available
2022-05-01
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-02
Call 1 — Left Voicemail
2022-10-29
Survey response — 12 months, dose 2
MedDRA: Oral herpes, Oropharyngeal pain, Rhinorrhoea, Secretion discharge — Feeling: Good

Free text: sore throat and herpes popped up on the lip. tormented by a runny nose and expectoration of mucus

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-01	Moderna	No
2	2021-10-29	Moderna	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — day 35, dose 2

2021-12-05

Symptoms: sore throat

Release 11 — 3 months, dose 2

2022-01-28

Symptoms: , . . 37,6. . . .

Release 11 — 6 months, dose 2

2022-05-01

Symptoms: runny nose, rhinitis. and cough

Release 12 — 12 months, dose 2

2022-10-29

Symptoms: sore throat and herpes popped up on the lip. tormented by a runny nose and expectoration of mucus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Oral herpes	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Rhinitis	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Secretion discharge	·	·	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release